Literature DB >> 16996579

The overlap of Sjögren's syndrome with other systemic autoimmune diseases.

Manuel Ramos-Casals1, Pilar Brito-Zerón, Josep Font.   

Abstract

OBJECTIVE: To analyze the main diagnostic problems caused by the overlap between Sjögren's syndrome (SS) and other systemic autoimmune diseases (SAD).
METHODS: We performed a MEDLINE search for articles published between January 1966 and December 2005 that specifically analyzed the overlap between SS and other SAD. We identified a list of diagnostic problems in patients with primary SS who had features considered typical of other SAD.
RESULTS: Clinically, the main diagnostic problems occur in SS patients presenting with arthritis, Raynaud phenomenon, cutaneous features (subacute cutaneous lupus erythematosus, purpura, livedo reticularis, erythema nodosum), interstitial pulmonary disease, and cytopenias (leukopenia, thrombocytopenia). Immunologically, antiphospholipid antibodies (aPL) and antineutrophil cytoplasmic antibodies (ANCA) are the most frequent atypical autoantibodies found in primary SS, with a prevalence ranging between 10 and 20%. However, coexisting antiphospholipid syndrome or systemic vasculitis is only detected in around 10% of SS patients with aPL or ANCA. Anti-DNA and anticentromere antibodies have a prevalence of 5 to 10%, but are more closely related to clinical and/or laboratory data suggestive of associated systemic lupus erythematosus and limited systemic sclerosis, respectively, leading to the fulfillment of classification criteria for these diseases in more than 25% of cases.
CONCLUSION: The wide variety of clinical and immunological manifestations of patients with primary SS often overlap with other SAD, making the differentiation between primary SS, SS associated with SAD, and SS-like presentations of some other SAD difficult. This overlap suggests that the current classification criteria are useful in differentiating between autoimmune and non-autoimmune processes but fail to clearly differentiate among SAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996579     DOI: 10.1016/j.semarthrit.2006.08.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  39 in total

Review 1.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

2.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

3.  Rheumatoid arthritis - an update for general dental practitioners.

Authors:  S de Souza; R K Bansal; J Galloway
Journal:  Br Dent J       Date:  2016-11-18       Impact factor: 1.626

Review 4.  Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.

Authors:  Elena Generali; Antonio Costanzo; Carlo Mainetti; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

5.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12

6.  X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.

Authors:  Margherita Sisto; Loredana Lorusso; Sabrina Lisi
Journal:  Clin Exp Med       Date:  2015-12-11       Impact factor: 3.984

7.  Autoimmune conditions and hairy cell leukemia: an exploratory case-control study.

Authors:  Lesley A Anderson; Eric A Engels
Journal:  J Hematol Oncol       Date:  2010-10-04       Impact factor: 17.388

Review 8.  [Vasculopathy in Sjögren's syndrome].

Authors:  E Feist; K-G A Hermann; A Dankof
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

9.  Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Marta Perez-De-Lis; Iratxe Jimenez; Maria-Jose Blanco; Albert Bove; Maria-Jose Soto; Miriam Akasbi; Candido Diaz; Juan Sentís; Antoni Siso
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 10.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.